PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
June 19, 2013European Heart Journal272 citationsOpen Access

Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial

View Full Paper
SWStephen G. WorthleyCTCostas TsioufisMWM. Worthley

Structured PICO

Does renal sympathetic denervation using the EnligHTN multi-electrode catheter reduce office blood pressure in patients with drug-resistant hypertension?

P
Population
Patients with drug-resistant hypertension
I
Intervention
Renal sympathetic denervation using the EnligHTN multi-electrode catheter
O
Outcome
Office blood pressure reduction and safetysurrogate

Renal sympathetic denervation using a multi-electrode catheter provides sustained blood pressure reduction at 6 months in patients with resistant hypertension.

Abstract

Renal sympathetic denervation, using the EnligHTN multi-electrode catheter results in a rapid and significant office blood pressure reduction that was sustained through 6 months. The EnligHTN system delivers a promising therapy for the treatment of drug-resistant hypertension.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Worthley et al. (2013) studied this question.

synapsesocial.com/papers/69effb1b4f6a06657c21e2echttps://doi.org/10.1093/eurheartj/eht197
Ask AI
Helpful
Bookmark
Share
View Full Paper